pharmatechoutlook
2NOVEMBER 2023EmulSolAmorSolNanoSolOUR TECHNOLOGIESĀ· Formulation Development for Poorly Soluble DrugsĀ· cGMP Manufacture for Clinical MaterialsĀ· CR, Parenteral & Topical Dosage Forms+1-732-640-0058ascendiapharma.com Delivering sophisticatedformulations.Making theimpossible possible.2021 Ascendia PTNA ad.indd 12021 Ascendia PTNA ad.indd 112/15/21 10:33 AM12/15/21 10:33 AM
< Page 1 | Page 3 >